These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38191231)

  • 21. Cardiovascular toxicity of minoxidil in the marmoset.
    Hanton G; Sobry C; Daguès N; Rochefort GY; Bonnet P; Eder V
    Toxicol Lett; 2008 Aug; 180(3):157-65. PubMed ID: 18582543
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of the anaesthetised guinea-pig in the preclinical cardiac safety evaluation of drug candidate compounds.
    Marks L; Borland S; Philp K; Ewart L; Lainée P; Skinner M; Kirk S; Valentin JP
    Toxicol Appl Pharmacol; 2012 Sep; 263(2):171-83. PubMed ID: 22714037
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hydroxypropyl-β-cyclodextrin impacts renal and systemic hemodynamics in the anesthetized dog.
    Rosseels ML; Delaunois AG; Hanon E; Guillaume PJ; Martin FD; van den Dobbelsteen DJ
    Regul Toxicol Pharmacol; 2013 Dec; 67(3):351-9. PubMed ID: 23978386
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative effects of levosimendan, OR-1896, OR-1855, dobutamine, and milrinone on vascular resistance, indexes of cardiac function, and O2 consumption in dogs.
    Banfor PN; Preusser LC; Campbell TJ; Marsh KC; Polakowski JS; Reinhart GA; Cox BF; Fryer RM
    Am J Physiol Heart Circ Physiol; 2008 Jan; 294(1):H238-48. PubMed ID: 17982006
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systemic and coronary hemodynamic effects of repetitive cocaine administration in conscious dogs.
    Pagel PS; Tessmer JP; Warltier DC
    J Cardiovasc Pharmacol; 1994 Sep; 24(3):443-53. PubMed ID: 7528301
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dasatinib can Impair Left Ventricular Mechanical Function But May Lack Proarrhythmic Effect: A Proposal of Non-clinical Guidance for Predicting Clinical Cardiovascular Adverse Events of Tyrosine Kinase Inhibitors.
    Izumi-Nakaseko H; Fujiyoshi M; Hagiwara-Nagasawa M; Goto A; Chiba K; Kambayashi R; Naito AT; Ando K; Kanda Y; Ishii I; Sugiyama A
    Cardiovasc Toxicol; 2020 Feb; 20(1):58-70. PubMed ID: 31280457
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiovascular pharmacology of the vasodilator-cardiotonic agent, 349U85.
    Steffen RP; Wastila WB
    J Cardiovasc Pharmacol; 1992 Oct; 20(4):579-89. PubMed ID: 1280714
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The inotropic and beta blocking effects of a chimeric molecule that putatively inhibits both type III phosphodiesterase and beta adrenoceptors in anesthetized dogs.
    Shaffer JE; Grizzle MK; Anderson DK; Wheeler TN
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1105-12. PubMed ID: 8099617
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of an investigative safety pharmacology model to assess comprehensive cardiac function and structure in chronically instrumented conscious beagle dogs.
    Regan CP; Stump GL; Detwiler TJ; Chen L; Regan HK; Gilberto DB; DeGeorge JJ; Sannajust FJ
    J Pharmacol Toxicol Methods; 2016; 81():107-14. PubMed ID: 27166580
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Positive inotropic and lusitropic effects of triiodothyronine in conscious dogs with pacing-induced cardiomyopathy.
    Jamall IN; Pagel PS; Hettrick DA; Lowe D; Kersten JR; Tessmer JP; Warltier DC
    Anesthesiology; 1997 Jul; 87(1):102-9. PubMed ID: 9232140
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of the pharmacological effects of inotropic drugs on left ventricular pressure and contractility: an evaluation of the QA interval as an indirect indicator of cardiac inotropism.
    Norton K; Iacono G; Vezina M
    J Pharmacol Toxicol Methods; 2009; 60(2):193-7. PubMed ID: 19523528
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacology of LY175326: a potent cardiotonic agent with vasodilator activities.
    Hayes JS; Pollock GD; Wilson H; Bowling N; Robertson DW
    J Pharmacol Exp Ther; 1985 May; 233(2):318-26. PubMed ID: 3999023
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Integrated approach to early detection of cardiovascular toxicity induced by a ghrelin receptor agonist.
    Stokes AH; Falls JG; Yoon L; Cariello N; Faiola B; Colton HM; Jordan HL; Berridge BR
    Int J Toxicol; 2015; 34(2):151-61. PubMed ID: 25722321
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Positive chronotropic and inotropic effects of pimobendan (UD-CG 115 BS) in isolated, cross-circulated canine heart preparations.
    Furukawa Y; Akahane K; Ogiwara Y; Haniuda M; Chiba S
    Arch Int Pharmacodyn Ther; 1989; 300():159-73. PubMed ID: 2575887
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacological studies with the alpha 2-adrenoceptor antagonist midaglizole. Part I: Respiratory and cardiovascular systems.
    Hirohashi M; Takasuna K; Yamashita N; Tamura K
    Arzneimittelforschung; 1991 Jan; 41(1):9-18. PubMed ID: 1675573
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of milrinone on echocardiographic parameters after single dose in Beagle dogs and relationship with drug-induced cardiotoxicity.
    Hanton G; Gautier M; Bonnet P; Herbet A
    Toxicol Lett; 2005 Feb; 155(2):307-17. PubMed ID: 15603926
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SC-36602, a new antiarrhythmic agent: comparison of its cardiovascular profile with that of other antiarrhythmic drugs.
    Frederick LG; Hatley FR; McDonald SJ; Stamm MH; Garthwaite SM
    J Cardiovasc Pharmacol; 1988 Jun; 11(6):657-66. PubMed ID: 2457760
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacology of LY195115, a potent, orally active cardiotonic with a long duration of action.
    Hayes JS; Pollock GD; Wilson H; Bowling N; Robertson DW
    J Cardiovasc Pharmacol; 1987 Apr; 9(4):425-34. PubMed ID: 2438505
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Negative inotropic effects of propofol as evaluated by the regional preload recruitable stroke work relationship in chronically instrumented dogs.
    Pagel PS; Warltier DC
    Anesthesiology; 1993 Jan; 78(1):100-8. PubMed ID: 8424542
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiovascular profile of Ro 13-6438, a novel positive inotropic agent with vasodilating properties.
    Eigenmann R; Gerold M; Holck M
    J Cardiovasc Pharmacol; 1984; 6(3):511-9. PubMed ID: 6202980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.